Médecins Sans Frontières (MSF)
Médecins Sans Frontières (MSF) or Doctors without Borders is an international, independent, medical humanitarian organisation that delivers emergency aid to people affected by armed conflict, epidemics, natural disasters and exclusion from healthcare. MSF offers assistance to people based on need, irrespective of race, religion, gender or political affiliation.
In 2016, we were proud to form a new 3-year partnership with MSF and their training and research arm Epicentre, a non-profit association embedded in the MSF movement to support the Niger Research Center. With $100,000 a year, the goal is to support MSF and Epicentre’s capacity building at the Center and support African driven research to improve medical practice within Niger and MSF as a whole.
The Elsevier Foundation grant is part of a larger Memorandum of Understanding between MSF, Epicentre, the Elsevier Foundation and Elsevier, the company providing in kind assistance through products, platforms, communications and expertise.
Supporting the Niger Research Center
Doctors, epidemiologists, biologists and data managers work on site at the Niger Research Center in close collaboration with the MSF teams, the Ministry of Public Health, NGOs, Institut Pasteur, the WHO and other international organizations. Located in the regional hospital of Maradi, it has a medical biology laboratory and the infrastructure necessary to undertake studies and data analysis. The Center’s focus areas include: the investigation of epidemics; implementation and assessment of alert and monitoring systems; prevalence surveys; and measurement of the coverage and impact of medical programs. Their goals is to provide concrete and adapted responses for better On preventive, diagnostic or therapeutic medical care within Niger and MSF as a whole.
- Capacity building of Epicentre’s core African team at all stages of the research process including the training of medical and scientific staff
- Holding an annual Epicentre Science Day to raise visibility with policymakers, researchers, journalists and funders and improving the dissemination of research results to promote relevant health policies in the region.
In January 2018, Epicentre held its first ever Scientific Day in Niamey, Niger, sharing critical work on the prevention of malaria, the new rotavirus vaccine and antibiotic resistance trends.
Read more about the partnership:
On SciDev.net: “Antibiotics resistance in Africa needs urgent attention“, Ochieng’ Ogodo, 22 March 2018
On The Lancet: “Local research in Africa: a glimpse at possibilities in Niger“, 1 March 2018
On Elsevier Connect: “Grant will support Doctors without Borders’ research and training hub in Niger“, Ylann Schemm, 25 October 2016
“Elsevier and Doctors without Borders Partner to Help Tackle Africa’s Health Challenges“, Press Office Amsterdam, 25 October 2016
Health & Innovation News
Meningitis, malaria and malnutrition are the biggest health challenges for the Sahel region – a geographical area just below the Sahara desert… [Read more]
Dr. Githinji Gitahi, Group CEO of Amref Health Africa, talks about Africa’s unique path to UHC and what to expect… [Read more]
The rising threat of antibiotics resistance in the Sub-Saharan Africa region is making interventions at policy and medical levels urgent, scientists say.… [Read more]
Amsterdam, May 19, 2017: PRESS RELEASE Amref Health Africa, Africa’s leading health organisation launched an investment fund focused on the… [Read more]
The Elsevier Foundation provides a three-year $300,000 grant to MSF/Epicentre’s Niger Research Center Amsterdam, October 25, 2016 Elsevier, a world-leading provider… [Read more]
An Elsevier Foundation partnership will provide $300,000, while Elsevier provides access to critical products and services Can a new heat-resistant… [Read more]
Amref Health Africa ramps up Jibu – Swahili for “answer” – a mobile nursing education app with support from the… [Read more]
New programs address Sustainability Development Goals Amsterdam, February 1, 2016 – The Elsevier Foundation has launched a series of new… [Read more]